Shankar Musunuri

Biography

 Dr. Musunuri is the Co-founder, Chairman and CEO of Ocugen, Inc. Dr. Musunuri is a seasoned biotech veteran with over 24 years of results-driven experience that includes advancing and commercializing a diverse portfolio of products for numerous companies ranging from “Big Pharma” to novel start-up biotechs. As a serial entrepreneur, Dr. Musunuri has raised upwards of $180 million in capital. Dr. Musunuri was the former President, Chief Executive Officer and board member of ioGenetics, Inc. Prior to ioGenetics, Dr. Musunuri was a Founder, President, Chief Executive Officer, and a board member of Nuron Biotech, Inc. Previously, Dr. Musunuri spent nearly fifteen years at Pfizer where he had held various positions of increasing leadership and responsibility. At Pfizer, his extensive experience in product launches and product life-cycle management included the most successful launch in vaccine history, Prevnar 13®, where he was played a key role as the Global Operations Team Leader. Prior to Pfizer, Dr. Musunuri worked for Amylin Pharmaceuticals. Dr. Musunuri has won numerous company, society and organizational awards. Dr. Musunuri obtained his PhD in Pharmaceutical Sciences from the University of Connecticut and an MBA from Duke University’s Fuqua School of Business. He is a recipient of the Distinguished Alumnus Award from the University of Connecticut’s School of Pharmacy. He serves on the Advisory Board of Fuqua’s Center for Entrepreneurship and Innovation.

Research Interest

 Pharmaceutical Sciences